Podcasts about psas

The Stuph File Program Featuring Humphrey Hawksley, author of The Rake Ozenna Series; Sebastien de Castell, author of The Malevolent Eight; & Stuart Nulman with Book Banter Download Humphrey Hawksley, a BBC foreign correspondent and the thriller author of The Rake Ozenna Series, featuring titles including Man on Ice, Man On Fire, Man On Edge and Ice Islands, talks about how sometimes his fiction comes true. Sebastien de Castell, author of The Malevolent Eight. It's the sequel to The Malevolent Seven. Stuart Nulman with another edition of Book Banter. This week's reviewed title is Knife by Salman Rushdie (Vintage Canada, $22).You can also read Stuart's articles in The Main and at BestStory.ca. This week's guest slate is presented by Mike Occomore, the executive producer of The Pro Bono Group, a company that produces PSAs, including the current Pro Canada PSA's featuring Canadian celebrities, which are currently running in this very show.  He was on show #0833 discussing the campaign and his company's PSA journey.

“Policies help make sure that we're giving patients the right education and discharge instructions. Radiation doesn't end when the syringe is empty. Patients go home with potential radioactive exposure. They need to know how to protect their families, what precautions to take, and what healthcare providers can do if something goes wrong—like a spill, extravasation, or even a pregnant staff member who's involved in the care. This isn't just a documentation exercise. It's about making sure every part of the system speaks the same language when it comes to safety, handling, and patient care,” ONS member Ella-Mae Shupe, MSN, RN, OCN®, nursing practice and professional development specialist for radiation oncology at Johns Hopkins Health System Sydney Kimmel Cancer Center based in Baltimore, MD, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about creating and implementing radiopharmaceutical policies and procedures.  Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 22, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learner will report an increase in knowledge related to implementing policies and procedures to support administration of radiopharmaceuticals for cancer treatment. Episode Notes   Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 347: Care Considerations for Radiopharmaceuticals and Theranostics in Patients With Cancer Episode 301: Radiation Oncology: Side Effect and Care Coordination Best Practices Episode 298: Radiation Oncology: Nursing's Essential Roles Episode 104: How Radiation Affects All Areas of Oncology Nursing ONS Voice articles: New Radiopharmaceutical Improves Survival in Advanced Prostate Cancer Radiopharmaceuticals and Theranostics Offer New Options for Oncology Nurses to Transform Cancer Care Radiopharmaceuticals Pack a One-Two Punch Against Cancer Safety Is Key in Use of Radiopharmaceuticals ONS Voice oncology drug reference sheets: Lutetium Lu 177 Dotatate Lutetium Lu 177 Vipivotide Tetraxetan Radium 223 Dichloride Sodium Iodide-131 ONS book: Manual for Radiation Oncology Nursing Practice and Education (Fifth Edition) ONS course: ONS/ONCC® Radiation Therapy Certificate™ Clinical Journal of Oncology Nursing article: Nursing Telemedicine Educational Encounters: Improved Patient Satisfaction in Radiation Therapy Clinics Other ONS resources: ONS Radiation Learning Library ONS Radiation Safety: In the Home Huddle Card ONS Radiopharmaceuticals Huddle Card Daily Med Lutathera® website for healthcare professionals Pluvicto® website for healthcare professionals Xofigo® website for healthcare professionals To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode  “[Lutetium lu 177 vipivotide tetraxetan] has shown so effective in clinical studies that the FDA recently approved expanded use, and it can now be given prior to chemotherapy.” TS 1:56 “There are typically three parts to a radiopharmaceutical. One is a radioisotope, which emits the radiation. The second is a targeting molecule, which directs the compound to a specific site. And the third is a linker that binds the isotope to the targeting molecules securely. The targeting molecule is usually a substance that binds specifically to receptors, antigens, or metabolic pathways that are overexpressed on cancer cells.” TS 2:08  “We have an interdisciplinary team involvement. There's a physicist, nurse, and provider that confirm lab values are within normal limits. The patient meets all the clinical and safety criteria for administration. Second is an IV placement where a nurse or clin tech starts the IV and verifies a strong blood return. This is critical to avoid extravasation, which can be harmful due to the vesicant-like nature of radiopharmaceuticals. And third, our patient voids immediately before the injection, which reduces bladder radiation dose. During the administration, our provider administers the radiopharmaceutical using a shielded syringe holder to reduce radiation exposure. The physicist remains present throughout the procedure. Lead aprons are worn by any team members close to the IV site, and then the Geiger counter is used by physics to measure ionizing radiation, which is done before, during, and after the procedure.” TS 3:28 “The policy we created doesn't just address general principles. It includes very specific guidance for both [radium 223 dichloride] and [lutetium lu 177 vipivotide tetraxetan]. That includes everything from determining patient eligibility to completing the treatment directive, confirming patient identity, verifying delivery parameters, documenting the treatment itself, and ensuring the treatment environment is appropriate and safe. We've also built in drug- specific practices because [radium 223 dichloride] and [lutetium lu 177 vipivotide tetraxetan] each come with their own considerations. This includes competencies for nursing, tailored patient education for each therapy, and an extravasation checklist that outlines what to do and who's responsible for tasks if infiltration occurs.”TS 11:24 “We created two separate versions [of an attestation model], one for clinical staff and one for non-clinical staff. Why include non-clinical staff? Because the risks extend beyond just the clinical team. What if environmental services comes in to clean and the patient has urinated on the floor? Or what if dietary delivers a tray and moves a urinal without knowing the risk? Or what if transport comes in and handles an incontinent brief without awareness? Each of these scenarios has potential for contamination and exposure. And that's exactly why education for all roles matter.” TS 15:22 “These are such an exciting treatment for our patients, that's not chemotherapy, that's not radiation, and their quality of life has been amazing. We have had patients coming in that could barely walk because of the pain from bone mets and after a few treatments, they're much better. We've had PSAs go from five, six hundreds down to 0.5, so we're seeing a lot of really good options for these patients and treatment.” TS 22:09  

[01:00:44] EU Push for WarOpening monologue frames EU leaders' Oval Office visit as another step toward World War III, warning of elites driving conflict. [01:02:13] Chemo Costs & CorruptionKansas woman forced to sell baked goods for $10,000/month chemo illustrates Big Pharma greed and insurance industry corruption, with added discussion of chemo's brain damage. [01:20:33] Soros & Ukraine RevolutionsClips of George Soros admitting to funding Ukraine's revolution reinforce claims of Western-engineered regime change and manufactured conflict. [01:23:02] COVID Propaganda MachineActors and government PSAs compared to “I play a doctor on TV,” exposing taxpayer-funded psy-ops that pushed vaccines and lockdowns. [01:27:00] NATO & Endless WarsCriticism of NATO as an entangling alliance meant to drag the U.S. into European wars, with sanctions framed as acts of war. [01:42:00] Culture Wars: Tradwives & FuentesAnalysis of “tradwife” influencers like Lauren Southern and Nick Fuentes, accusing them of cosplaying tradition and discouraging real families, seen as controlled opposition undermining Western civilization. [02:25:03] Milo & the Right-Wing CircusDiscussion of Milo Yiannopoulos as an unstable provocateur, linked to Alex Jones, with comparisons to Laura Loomer; highlights the grifter culture. [02:25:44] AI as Modern IdolatryHealth Impact article sparks a segment framing AI as today's “talking idols,” reflecting human emptiness rather than true intelligence. [02:45:30] CRISPR & AI GeneticsConcerns raised that CRISPR gene editing is more like a chainsaw than a scalpel, with elites now turning to AI to “clean up” dangerous genetic manipulation. [02:49:19] De-Banking & StablecoinsDiscussion of Bank of America walking back “debanking” rules against religious groups, but warning that stablecoins are a Trojan horse for CBDCs and government financial control. [03:11:01] Trump Tariffs & Food CostsNew tariffs on Brazil, Switzerland, and Mexico predicted to raise prices on coffee, chocolate, olive oil, and groceries. Large corporations can absorb costs temporarily, but small businesses and consumers will feel the squeeze. [03:29:48] Israeli Official & Sex CrimesCoverage of an Israeli official caught in a Nevada sex crime sting but quietly returned to Israel, sparking discussion of influence, Epstein networks, and government protection of predators. [03:44:05] Pornography, AI & Spiritual WarAnalysis of how pornography addiction undermines churches, worsened by AI chatbots and virtual companions that manipulate users — framed as a spiritual battle for minds and families. Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

[01:00:44] EU Push for WarOpening monologue frames EU leaders' Oval Office visit as another step toward World War III, warning of elites driving conflict. [01:02:13] Chemo Costs & CorruptionKansas woman forced to sell baked goods for $10,000/month chemo illustrates Big Pharma greed and insurance industry corruption, with added discussion of chemo's brain damage. [01:20:33] Soros & Ukraine RevolutionsClips of George Soros admitting to funding Ukraine's revolution reinforce claims of Western-engineered regime change and manufactured conflict. [01:23:02] COVID Propaganda MachineActors and government PSAs compared to “I play a doctor on TV,” exposing taxpayer-funded psy-ops that pushed vaccines and lockdowns. [01:27:00] NATO & Endless WarsCriticism of NATO as an entangling alliance meant to drag the U.S. into European wars, with sanctions framed as acts of war. [01:42:00] Culture Wars: Tradwives & FuentesAnalysis of “tradwife” influencers like Lauren Southern and Nick Fuentes, accusing them of cosplaying tradition and discouraging real families, seen as controlled opposition undermining Western civilization. [02:25:03] Milo & the Right-Wing CircusDiscussion of Milo Yiannopoulos as an unstable provocateur, linked to Alex Jones, with comparisons to Laura Loomer; highlights the grifter culture. [02:25:44] AI as Modern IdolatryHealth Impact article sparks a segment framing AI as today's “talking idols,” reflecting human emptiness rather than true intelligence. [02:45:30] CRISPR & AI GeneticsConcerns raised that CRISPR gene editing is more like a chainsaw than a scalpel, with elites now turning to AI to “clean up” dangerous genetic manipulation. [02:49:19] De-Banking & StablecoinsDiscussion of Bank of America walking back “debanking” rules against religious groups, but warning that stablecoins are a Trojan horse for CBDCs and government financial control. [03:11:01] Trump Tariffs & Food CostsNew tariffs on Brazil, Switzerland, and Mexico predicted to raise prices on coffee, chocolate, olive oil, and groceries. Large corporations can absorb costs temporarily, but small businesses and consumers will feel the squeeze. [03:29:48] Israeli Official & Sex CrimesCoverage of an Israeli official caught in a Nevada sex crime sting but quietly returned to Israel, sparking discussion of influence, Epstein networks, and government protection of predators. [03:44:05] Pornography, AI & Spiritual WarAnalysis of how pornography addiction undermines churches, worsened by AI chatbots and virtual companions that manipulate users — framed as a spiritual battle for minds and families. Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silverFor 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHTFind out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

Ops Quickies – snackable episodes on tech, tools, and systems.

On this Monday Night edition of the American Scouser Podcast, we break down the impact of Luis Díaz's move to Bayern Munich and what it could mean for Liverpool's summer strategy. Does this accelerate the push for Alexander Isak, or is the saga starting to cool?We also dig into transfer rumors, squad depth concerns, and how this shift might affect the front line heading into the new season.Join us for a deep dive full of insight, banter, and the latest LFC buzz—plus our usual Monday night vibes.

Don't do these things! In this episode, Rhett & Link are giving multiple PSAs – from speakerphones in public to perfect beard trimming to bad breath. Plus, Rhett talks about a plane passenger that nearly sent him over the edge – was he right in his thinking? Leave us a voicemail at 1-888-EARPOD-1 for a chance to be featured on the show. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

It's Wednesday, July 23rd, A.D. 2025. This is The Worldview in 5 Minutes heard on 140 radio stations and at www.TheWorldview.com.  I'm Adam McManus. (Adam@TheWorldview.com) By Jonathan Clark and Adam McManus Muslims kill Syrian pastor and 20 members of family Syrian Muslims took the life of a pastor and 20 members of his family over the weekend. Khalid Mezher was the pastor of the Good Shepherd Evangelical Church in southern Syria. He and his family converted to Christianity years ago out of a religious group in the area known as the Druze.  Violence between Druze militias and fighters from the Bedouin tribes, which are mostly Muslim, has taken the lives of hundreds of people over the last week.  Evangelical leader Johnnie Moore wrote on X, “Pastor Khalid died for a faith that many Christians hardly live. They are now martyrs who gave their entire lives, in difficult circumstances, to share the love of Jesus with their neighbors and beloved Syria.” In Matthew 16:25, Jesus said, “For whoever desires to save his life will lose it, but whoever loses his life for My sake will find it.” Puerto Rico protects kids from transsexual drugs and surgeries Puerto Rico is protecting children from transsexual drugs and surgeries. Last Wednesday, Republican Governor Jenniffer González Colón signed the Law for the Protection of the Health and Well-being of Minors in Puerto Rico. Harming children with such transsexual procedures is punishable by 15 years in prison.   Puerto Rico joins nearly 30 states in America with similar bans. Japan to invest $550 billion into America President Donald Trump secured a great deal with Japan, reports The Epoch Times. On Truth Social, President Trump announced, “We just completed a massive deal with Japan, perhaps the largest deal ever made. Japan will invest, at my direction, $550 billion into the United States, which will receive 90% of the profits. “This deal will create hundreds of thousands of jobs. There has never been anything like it. Perhaps most importantly, Japan will open their country to trade including cars and trucks, rice and certain other agricultural products. … Japan will pay reciprocal tariffs to the United States of 15%.” CBS/Skydance to pay Trump Foundation $36 million President Trump recently reached a $16 million settlement with Paramount, the parent of CBS News, over what he claimed was misleading editing of a pre-election interview with the Democratic candidate for president, Kamala Harris, reports The Guardian. While CBS initially called the lawsuit “completely without merit”, Paramount is in the midst of an $8 billion sale to the Hollywood studio Skydance Media, which requires the approval of federal regulators. President Trump has claimed that the future owner of CBS will provide him with $20 million worth of advertising and programming – days after the network canceled The Late Show With Stephen Colbert. On Truth Social, Trump wrote, “We have just achieved a BIG AND IMPORTANT WIN in our historic lawsuit against 60 Minutes, CBS, and Paramount. … CBS and its corporate owners knew that they defrauded the American people, and were desperate to settle. Paramount/CBS/60 Minutes have today paid $16 Million in settlement, and we also anticipate receiving $20 million more from the new owners, in advertising, PSAs, or similar programming, for a total of over $36 million dollars.” He added, “This is another in a long line of VICTORIES over the Fake News Media, who we are holding to account for their widespread fraud and deceit. The Wall Street Journal, The Failing New York Times, The Washington Post, MSDNC, CNN, and all other Mainstream Media Liars, are ON NOTICE that the days of them being allowed to deceive the American people are OVER.” Federal workforce shrunk by 22,000 people A report by the Federal Reserve Bank of Richmond found the U.S. federal workforce has shrunk by over 22,000 people from January to May of this year. Chuck Ezell, the Acting Director of the U.S. Office of Personnel Management, said, “The American people deserve a government that is lean, efficient, and focused on core priorities. This data marks the first measurable step toward President Trumpʼs vision of a disciplined, accountable federal workforce and itʼs only the beginning.” Trump has also extended his hiring freeze on federal workers through October. Foreign buyers purchased $56 billion worth of U.S. homes The National Association of Realtors reports that foreign buyers purchased $56 billion worth of U.S. homes from April 2024 through March 2025. The number of home purchases by foreign buyers rose to over 78,000 this year. That's up from last year's report, but still down from 284,000 purchases in 2017.  The top destination states for foreign buyers include Florida, California, Texas, and New York. The most popular origin countries of international buyers are China, Canada, Mexico, India, and the United Kingdom. China's share of buyers has gone up significantly since 2007. Star from The Cosby Show drowned Malcolm-Jamal Warner, who portrayed the teenage son Theo Huxtable on “The Cosby Show”, died at 54 in an accidental drowning in Costa Rica, reports the Associated Press. Costa Rica's Judicial Investigation Department said Warner drowned Sunday afternoon, July 20th on a beach on Costa Rica's Limón province when a current pulled him deeper into the ocean. His character, Theo, was the only son among four daughters in the household of Cosby's Cliff Huxtable and Phylicia Rashad's Clair Huxtable on the NBC sitcom. He was one of the prime representations of American teenage life and Black boyhood on a show that was the most popular in America for much of its run from 1984 to 1992. Christian golfer says priorities are faith, family, then golf And finally, Scottie Scheffler won the Open Championship earlier this week. Also known as the British Open, it's the oldest golf tournament in the world.  The American professional golfer has won 20 times worldwide since 2022. After his latest victory, Scheffler told reporters he enjoys golf but that faith and family are his greatest priorities.  SCHEFFLER: “I would say my greatest priorities are my faith and my family. Those come first for me. Golf is third in that I've said it for a long time. Golf is not how I identify myself. I don't identify myself by winning tournaments, chasing trophies, being famous or whatever it is. “This week, I was the best player in the world. I'm sitting here with the trophy. We're gonna start all over in Memphis, back to even par. Show goes on. I don't feel any different because I've won a golf tournament. This is not the ‘be all end all' for me, but I'm extremely grateful for it. “I don't think that I'm anything special, just because some weeks, I'm better at shooting a lower score than other guys are.” Scheffler's love for family inspired a Nike ad that celebrates fatherhood. The footwear company posted a picture of Scheffler on the golf course with his infant son. Nike wrote, “Priorities unchanged. Another major secured. The wins keep coming on and off the course for Scottie Scheffler.” Close And that's The Worldview on this Wednesday, July 23rd, in the year of our Lord 2025. Follow us on X or subscribe for free by Spotify, Amazon Music, or by iTunes or email to our unique Christian newscast at www.TheWorldview.com.  Plus, you can get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.

In this episode of AwesomeCast, co-hosts Michael Sorg and Dave Podnar dive into the latest tech trends, gadgets, and geek culture from Pittsburgh and beyond. Sorg shares a hands-on review of the Backbone USB-C mobile game controller, and Dave unveils a jaw-dropping 115-inch Hisense Mini-LED TV that costs as much as a car. We explore tech headlines including the consolidation of ChromeOS and Android, Google's AI-powered NotebookLM, and how Xbox is pushing console-less gaming with Fire TV bundles. Plus, hear from Intern John about Picklesburgh adventures and travel plans, and enjoy a rapid-fire roundup in Chachi's Video Game Minute, featuring a major shakeup on Steam and FBI action on ROM sites.

In this episode of AwesomeCast, co-hosts Michael Sorg and Dave Podnar dive into the latest tech trends, gadgets, and geek culture from Pittsburgh and beyond. Sorg shares a hands-on review of the Backbone USB-C mobile game controller, and Dave unveils a jaw-dropping 115-inch Hisense Mini-LED TV that costs as much as a car. We explore tech headlines including the consolidation of ChromeOS and Android, Google's AI-powered NotebookLM, and how Xbox is pushing console-less gaming with Fire TV bundles. Plus, hear from Intern John about Picklesburgh adventures and travel plans, and enjoy a rapid-fire roundup in Chachi's Video Game Minute, featuring a major shakeup on Steam and FBI action on ROM sites.

New series alert: Ops Quickies — snackable episodes on tech, tools, and systems.

Sisters Olympia and Penelope Derr created PSAs about supporting their Haitian neighbors in Springfield, OH. The PSAs encourage people to be inclusive and compassionate.

The debate over whether Apple should acquire an AI company to stay competitive, with Perplexity as a leading candidate, is a hot topic. Chuck Joiner, David Ginsburg, Web Bixby, Eric Bolden, Marty Jencius, Jim Rea, and Brian Flanigan-Arthurs explore past acquisitions, Apple's AI strategy, and the challenges of merging company cultures. PSAs about malware from screenshots and fake CAPTCHAs are discussed, along with the growing risks of AI litigation and the hype vs. reality of AI's future.  Today's MacVoices is supported by Bzigo. Don't wait until the next bite—protect your home with Bzigo. Go to bzigo.com/discount/BUZZ10 to save 10% off. Show Notes: Chapters: 00:07 Introduction to Apple and AI01:45 Panel Introductions06:51 Public Service Announcements07:50 Apple's AI Acquisition Debate20:56 Mark Fuccio's Departure21:15 Bzigo Sponsorship Announcement22:42 Marty Gensius on AI Perspectives28:21 The Future of AI and Apple31:24 Closing Thoughts on Apple and Acquisitions36:38 AI Singularity vs. Limitations Links: There's New Reason to Never Keep Screenshots of Private Information on Your Phonehttps://lifehacker.com/tech/never-keep-private-information-screenshots-on-phone Watch Out for Fake CAPTCHAs That Spread Malware
 https://lifehacker.com/tech/captcha-malware-warning Apple Will Need to Leave Its M&A Comfort Zone to Succeed in AIhttps://archive.is/Z2ULZ Guests: Web Bixby has been in the insurance business for 40 years and has been an Apple user for longer than that.You can catch up with him on Facebook, Twitter, and LinkedIn. Eric Bolden is into macOS, plants, sci-fi, food, and is a rural internet supporter. You can connect with him on Twitter, by email at embolden@mac.com, on Mastodon at @eabolden@techhub.social, on his blog, Trending At Work, and as co-host on The Vision ProFiles podcast. Brian Flanigan-Arthurs is an educator with a passion for providing results-driven, innovative learning strategies for all students, but particularly those who are at-risk. He is also a tech enthusiast who has a particular affinity for Apple since he first used the Apple IIGS as a student. You can contact Brian on twitter as @brian8944. He also recently opened a Mastodon account at @brian8944@mastodon.cloud. David Ginsburg is the host of the weekly podcast In Touch With iOS where he discusses all things iOS, iPhone, iPad, Apple TV, Apple Watch, and related technologies. He is an IT professional supporting Mac, iOS and Windows users. Visit his YouTube channel at https://youtube.com/daveg65 and find and follow him on Twitter @daveg65 and on Mastodon at @daveg65@mastodon.cloud. Dr. Marty Jencius has been an Associate Professor of Counseling at Kent State University since 2000. He has over 120 publications in books, chapters, journal articles, and others, along with 200 podcasts related to counseling, counselor education, and faculty life. His technology interest led him to develop the counseling profession ‘firsts,' including listservs, a web-based peer-reviewed journal, The Journal of Technology in Counseling, teaching and conferencing in virtual worlds as the founder of Counselor Education in Second Life, and podcast founder/producer of CounselorAudioSource.net and ThePodTalk.net. Currently, he produces a podcast about counseling and life questions, the Circular Firing Squad, and digital video interviews with legacies capturing the history of the counseling field. This is also co-host of The Vision ProFiles podcast. Generally, Marty is chasing the newest tech trends, which explains his interest in A.I. for teaching, research, and productivity. Marty is an active presenter and past president of the NorthEast Ohio Apple Corp (NEOAC). Jim Rea built his own computer from scratch in 1975, started programming in 1977, and has been an independent Mac developer continuously since 1984. He is the founder of ProVUE Development, and the author of Panorama X, ProVUE's ultra fast RAM based database software for the macOS platform. He's been a speaker at MacTech, MacWorld Expo and other industry conferences. Follow Jim at provue.com and via @provuejim@techhub.social on Mastodon. Support:      Become a MacVoices Patron on Patreon     http://patreon.com/macvoices      Enjoy this episode? Make a one-time donation with PayPal Connect:      Web:     http://macvoices.com      Twitter:     http://www.twitter.com/chuckjoiner     http://www.twitter.com/macvoices      Mastodon:     https://mastodon.cloud/@chuckjoiner      Facebook:     http://www.facebook.com/chuck.joiner      MacVoices Page on Facebook:     http://www.facebook.com/macvoices/      MacVoices Group on Facebook:     http://www.facebook.com/groups/macvoice      LinkedIn:     https://www.linkedin.com/in/chuckjoiner/      Instagram:     https://www.instagram.com/chuckjoiner/ Subscribe:      Audio in iTunes     Video in iTunes      Subscribe manually via iTunes or any podcatcher:      Audio: http://www.macvoices.com/rss/macvoicesrss      Video: http://www.macvoices.com/rss/macvoicesvideorss

The debate over whether Apple should acquire an AI company to stay competitive, with Perplexity as a leading candidate, is a hot topic. Chuck Joiner, David Ginsburg, Web Bixby, Eric Bolden, Marty Jencius, Jim Rea, and Brian Flanigan-Arthurs explore past acquisitions, Apple's AI strategy, and the challenges of merging company cultures. PSAs about malware from screenshots and fake CAPTCHAs are discussed, along with the growing risks of AI litigation and the hype vs. reality of AI's future.  Today's MacVoices is supported by Bzigo. Don't wait until the next bite—protect your home with Bzigo. Go to bzigo.com/discount/BUZZ10 to save 10% off. Show Notes: Chapters: 00:07 Introduction to Apple and AI 01:45 Panel Introductions 06:51 Public Service Announcements 07:50 Apple's AI Acquisition Debate 20:56 Mark Fuccio's Departure 21:15 Bzigo Sponsorship Announcement 22:42 Marty Gensius on AI Perspectives 28:21 The Future of AI and Apple 31:24 Closing Thoughts on Apple and Acquisitions 36:38 AI Singularity vs. Limitations Links: There's New Reason to Never Keep Screenshots of Private Information on Your Phone https://lifehacker.com/tech/never-keep-private-information-screenshots-on-phone Watch Out for Fake CAPTCHAs That Spread Malware
https://lifehacker.com/tech/captcha-malware-warning Apple Will Need to Leave Its M&A Comfort Zone to Succeed in AI https://archive.is/Z2ULZ Guests: Web Bixby has been in the insurance business for 40 years and has been an Apple user for longer than that.You can catch up with him on Facebook, Twitter, and LinkedIn. Eric Bolden is into macOS, plants, sci-fi, food, and is a rural internet supporter. You can connect with him on Twitter, by email at embolden@mac.com, on Mastodon at @eabolden@techhub.social, on his blog, Trending At Work, and as co-host on The Vision ProFiles podcast. Brian Flanigan-Arthurs is an educator with a passion for providing results-driven, innovative learning strategies for all students, but particularly those who are at-risk. He is also a tech enthusiast who has a particular affinity for Apple since he first used the Apple IIGS as a student. You can contact Brian on twitter as @brian8944. He also recently opened a Mastodon account at @brian8944@mastodon.cloud. David Ginsburg is the host of the weekly podcast In Touch With iOS where he discusses all things iOS, iPhone, iPad, Apple TV, Apple Watch, and related technologies. He is an IT professional supporting Mac, iOS and Windows users. Visit his YouTube channel at https://youtube.com/daveg65 and find and follow him on Twitter @daveg65 and on Mastodon at @daveg65@mastodon.cloud. Dr. Marty Jencius has been an Associate Professor of Counseling at Kent State University since 2000. He has over 120 publications in books, chapters, journal articles, and others, along with 200 podcasts related to counseling, counselor education, and faculty life. His technology interest led him to develop the counseling profession ‘firsts,' including listservs, a web-based peer-reviewed journal, The Journal of Technology in Counseling, teaching and conferencing in virtual worlds as the founder of Counselor Education in Second Life, and podcast founder/producer of CounselorAudioSource.net and ThePodTalk.net. Currently, he produces a podcast about counseling and life questions, the Circular Firing Squad, and digital video interviews with legacies capturing the history of the counseling field. This is also co-host of The Vision ProFiles podcast. Generally, Marty is chasing the newest tech trends, which explains his interest in A.I. for teaching, research, and productivity. Marty is an active presenter and past president of the NorthEast Ohio Apple Corp (NEOAC). Jim Rea built his own computer from scratch in 1975, started programming in 1977, and has been an independent Mac developer continuously since 1984. He is the founder of ProVUE Development, and the author of Panorama X, ProVUE's ultra fast RAM based database software for the macOS platform. He's been a speaker at MacTech, MacWorld Expo and other industry conferences. Follow Jim at provue.com and via @provuejim@techhub.social on Mastodon. Support:      Become a MacVoices Patron on Patreon      http://patreon.com/macvoices      Enjoy this episode? Make a one-time donation with PayPal Connect:      Web:      http://macvoices.com      Twitter:      http://www.twitter.com/chuckjoiner      http://www.twitter.com/macvoices      Mastodon:      https://mastodon.cloud/@chuckjoiner      Facebook:      http://www.facebook.com/chuck.joiner      MacVoices Page on Facebook:      http://www.facebook.com/macvoices/      MacVoices Group on Facebook:      http://www.facebook.com/groups/macvoice      LinkedIn:      https://www.linkedin.com/in/chuckjoiner/      Instagram:      https://www.instagram.com/chuckjoiner/ Subscribe:      Audio in iTunes      Video in iTunes      Subscribe manually via iTunes or any podcatcher:      Audio: http://www.macvoices.com/rss/macvoicesrss      Video: http://www.macvoices.com/rss/macvoicesvideorss

Ivan Rubenstein-Gillis! Singer! Songwriter! Producer! Dear old friend! Delight! I've known Ivan for decades and I've always loved his music AND talking to him, so having him on my podcast to talk about his music AND MORE was perfect. Under the band name 500 Suns, he's got a new album "Hungry Man" coming out in July 2025! Stay tuned for that, and also stay tuned at the end of this podcast episode for a sneak peek of some music from that project! We have a great chat and you can have a great listen! PS This is only the first HALF of our chat. For the second half, subscribe via Apple Podcasts or merely click on over here to Patreon! Also, here's more about Ivan in Ivan's website's own words: "Ivan Rubenstein-Gillis is a singer, songwriter, producer and multi-instrumentalist based out of New York. With deep roots in folk, rock, jazz, world music and modern poetics, Ivan brings a rare sense of craft, intellectual provocation and emotional expression to his work.​ Ivan grew up in a creative family and from an early age was exposed to great music, books and visual art from all around the world. He played piano as a kid and began putting lyrics and chord patterns together around the age of 10 ... Bought his first guitar in high school and later added mandolin, banjo, harmonica, bass and other instruments to the mix. Over the course of his eclectic career, Ivan has written hundreds of songs and instrumental pieces, produced and recorded albums across various genres, composed for dance and theater and performed with great musicians in many styles.​ The primary focus of Ivan's creative life has been his songwriting. To date, he has recorded 11 albums of original material as a solo artist, collaborating with extraordinary rhythm sections, instrumentalists and singers along the way. His songs have won grants and awards, have been performed by numerous artists and choirs, have been featured in a number of movies, documentaries and PSAs, and have become part of the American musical landscape for his many admirers.​​ Two of his songs were featured in a worldwide viral video produced for the United Nations Environmental Program regarding the evils of single-use plastics. Outside of his own material, Ivan enjoyed a very successful collaboration with legendary trombonist Roswell Rudd over the last decade of his life. Ivan played with Rudd's dynamic MaliCool band in 2007 and produced Feeling Good (a tribute to Nina Simone) - the lead track off of Rudd's 2011 album The Incredible Honk.  In 2013-2014, Ivan produced Trombone For Lovers, an epic collection of American standards which included the house band of John Medeski, Aaron Comess and Richard Hammond, plus guest appearances from Bob Dorough, Faye Victor, Gary Lucas, Michael Doucet, Steven Bernstein, The NYC Labor Choir and other luminaries. TFL received a four star review in Downbeat and generated raves around the world. Roswell performed with Ivan and his band on numerous occasions and guested on several of Ivan's albums, including in the guise of a braying elephant on dogz and katz, a choice cut from Ivan's 2016 album The Lion. Ivan and Roswell continued to work together on new compositions and arrangements right up until Roswell died in December of 2017.​ Ivan produced and played multiple instruments on "Songs From Home" - a well-received  'pandemic EP' with fellow Rudd collaborator (and wonderful singer ) Heather Masse, featuring some of their favorite classics, reimagined for quarantine. Ivan's latest project - 500 Suns - is a collaboration with the great rhythm section of Craig Santiago and Scott Petito - an uplifting soulful band based out of the Hudson Valley featuring Shawn Dawn, Kendra McKinley and Leslie Ritter on vocals. ​Ivan's deep love for many different types of music has allowed him to play around the margins of numerous genres, and has led to longstanding musical relationships with Meyer Horn (drums), Adam Small (bass), Craig Santiago (drums), Scott Petito (bass), Aaron Comess (drums), Richard Hammond (bass), Heather Masse (voice), Cat Martino (voice), Leah Siegel (voice), Lexy Casano (cabaret artist), Clarence Ferrari (flame throwing fiddler), Arne Wendt (organist), Rod Sherwood (producer), David Grausman (piano) and David Brahinsky (NJ-based folksinger), among many others. Ivan has also worked extensively as a music educator, concert producer and "musical activist" - utilizing his talent and experience in the service of providing musical opportunities to underserved populations. Ivan has played at countless benefit concerts, fundraisers and community events and always appreciates the opportunity to play music in the service of a worthy cause.  Along with the music, Ivan writes satire, short stories, poems and the occasional expository essay. He also likes to draw funny sketches." Thanks and love, all!

Greetings

Jim and Chris shares listener PSAs on IRMAA and Delayed Retirement Credits, and answer questions on Social Security Spousal Benefits, annuity use cases, and fixed indexed annuity payout concerns. (13:00) A listener shares a PSA about a positive Medicare and IRMAA reduction experience at a Central Florida SSA office. (19:00) Georgette follows up with a […] The post PSAs, Spousal Benefits, Annuity Use Cases, and FIAs: Q&A #2526 appeared first on The Retirement and IRA Show.

Eric Deggans chats with veteran sitcom showrunner Phil Rosenthal about the current state of the industry. The creator of Everybody Loves Raymond and host of the unscripted Netflix series Somebody Feed Phil reflects on how studios shape viewership data to fit their narratives. Rosenthal recalls challenging flawed testing at CBS early in his career and he reflects on the success of Raymond. He also shares how he pitched his food and travel series as: “Anthony Bourdain if he was afraid of everything.”     But first, we banter! As the Donald Trump-Paramount Global lawsuit continues, a mediator has floated a proposed settlement: $20 million, including a $17 million donation to Trump’s presidential foundation, plus legal fees and anti-semitism PSAs. Kim Masters and Matt Belloni unpack the latest chapter in the president’s standoff with Shari Redstone.  

Eric Deggans chats with veteran sitcom showrunner Phil Rosenthal about the current state of the industry. The creator of Everybody Loves Raymond and host of the unscripted Netflix series Somebody Feed Phil reflects on how studios shape viewership data to fit their narratives. Rosenthal recalls challenging flawed testing at CBS early in his career and he reflects on the success of Raymond. He also shares how he pitched his food and travel series as: “Anthony Bourdain if he was afraid of everything.”   But first, we banter! As the Donald Trump-Paramount Global lawsuit continues, a mediator has floated a proposed settlement: $20 million, including a $17 million donation to Trump's presidential foundation, plus legal fees and anti-semitism PSAs. Kim Masters and Matt Belloni unpack the latest chapter in the president's standoff with Shari Redstone.

This MacVoices Live! discussion starts off with three essential public service announcements: a major recall of Anker PowerCore batteries, warnings about malicious unsubscribe links in emails, and serious privacy concerns surrounding Meta's AI assistant. The panel of Chuck Joiner, David Ginsburg, Jim Rea, Web Bixby, Brian Flanigan-Arthurs, and Marty Jencius emphasizes the importance of staying alert to avoid real-world risks. Jim Ray then shares a developer-focused perspective on WWDC, highlighting SwiftUI upgrades, AI integration in Xcode, and Apple's new foundation models. He also reflects on a week filled with events, developer camaraderie, and why WWDC 2025 might have been one of the best weeks of his life.  Today's MacVoices is supported by CleanMyMac by MacPaw, your ultimate solution for Mac control and clair. Try CleanMyMac for 7 days free, then use the code “MacVoices20” for 20% off at CLNMY.com/macvoices. Show Notes: Chapters: 00:11 Welcome to MacVoices01:16 Essential Public Service Announcements10:56 Jim's WWDC Experience19:31 Developer Insights from WWDC20:08 Jim's Memorable Week at WWDC26:02 Reflections on the Experience Links: Anker Recalls 1.1 Million PowerCore 10000 Power Bankshttps://tidbits.com/2025/06/13/anker-recalls-1-1-million-powercore-10000-power-banks/ Watch Out for Malicious Unsubscribe Linkshttps://lifehacker.com/tech/watch-out-for-malicious-unsubscribe-links Your Questions in the Meta AI App Might Be Posted Publiclyhttps://lifehacker.com/tech/how-to-keep-your-meta-ai-questions-private Guests: Web Bixby has been in the insurance business for 40 years and has been an Apple user for longer than that.You can catch up with him on Facebook, Twitter, and LinkedIn. Brian Flanigan-Arthurs is an educator with a passion for providing results-driven, innovative learning strategies for all students, but particularly those who are at-risk. He is also a tech enthusiast who has a particular affinity for Apple since he first used the Apple IIGS as a student. You can contact Brian on twitter as @brian8944. He also recently opened a Mastodon account at @brian8944@mastodon.cloud. David Ginsburg is the host of the weekly podcast In Touch With iOS where he discusses all things iOS, iPhone, iPad, Apple TV, Apple Watch, and related technologies. He is an IT professional supporting Mac, iOS and Windows users. Visit his YouTube channel at https://youtube.com/daveg65 and find and follow him on Twitter @daveg65 and on Mastodon at @daveg65@mastodon.cloud. Dr. Marty Jencius has been an Associate Professor of Counseling at Kent State University since 2000. He has over 120 publications in books, chapters, journal articles, and others, along with 200 podcasts related to counseling, counselor education, and faculty life. His technology interest led him to develop the counseling profession ‘firsts,' including listservs, a web-based peer-reviewed journal, The Journal of Technology in Counseling, teaching and conferencing in virtual worlds as the founder of Counselor Education in Second Life, and podcast founder/producer of CounselorAudioSource.net and ThePodTalk.net. Currently, he produces a podcast about counseling and life questions, the Circular Firing Squad, and digital video interviews with legacies capturing the history of the counseling field. This is also co-host of The Vision ProFiles podcast. Generally, Marty is chasing the newest tech trends, which explains his interest in A.I. for teaching, research, and productivity. Marty is an active presenter and past president of the NorthEast Ohio Apple Corp (NEOAC). Jim Rea built his own computer from scratch in 1975, started programming in 1977, and has been an independent Mac developer continuously since 1984. He is the founder of ProVUE Development, and the author of Panorama X, ProVUE's ultra fast RAM based database software for the macOS platform. He's been a speaker at MacTech, MacWorld Expo and other industry conferences. Follow Jim at provue.com and via @provuejim@techhub.social on Mastodon. Support:      Become a MacVoices Patron on Patreon     http://patreon.com/macvoices      Enjoy this episode? Make a one-time donation with PayPal Connect:      Web:     http://macvoices.com      Twitter:     http://www.twitter.com/chuckjoiner     http://www.twitter.com/macvoices      Mastodon:     https://mastodon.cloud/@chuckjoiner      Facebook:     http://www.facebook.com/chuck.joiner      MacVoices Page on Facebook:     http://www.facebook.com/macvoices/      MacVoices Group on Facebook:     http://www.facebook.com/groups/macvoice      LinkedIn:     https://www.linkedin.com/in/chuckjoiner/      Instagram:     https://www.instagram.com/chuckjoiner/ Subscribe:      Audio in iTunes     Video in iTunes      Subscribe manually via iTunes or any podcatcher:      Audio: http://www.macvoices.com/rss/macvoicesrss      Video: http://www.macvoices.com/rss/macvoicesvideorss

This MacVoices Live! discussion starts off with three essential public service announcements: a major recall of Anker PowerCore batteries, warnings about malicious unsubscribe links in emails, and serious privacy concerns surrounding Meta's AI assistant. The panel of Chuck Joiner, David Ginsburg, Jim Rea, Web Bixby, Brian Flanigan-Arthurs, and Marty Jencius emphasizes the importance of staying alert to avoid real-world risks. Jim Rea then shares a developer-focused perspective on WWDC, highlighting SwiftUI upgrades, AI integration in Xcode, and Apple's new foundation models. He also reflects on a week filled with events, developer camaraderie, and why WWDC 2025 might have been one of the best weeks of his life.  Today's MacVoices is supported by CleanMyMac by MacPaw, your ultimate solution for Mac control and clair. Try CleanMyMac for 7 days free, then use the code “MacVoices20” for 20% off at CLNMY.com/macvoices. Show Notes: Chapters: 00:11 Welcome to MacVoices 01:16 Essential Public Service Announcements 10:56 Jim's WWDC Experience 19:31 Developer Insights from WWDC 20:08 Jim's Memorable Week at WWDC 26:02 Reflections on the Experience Links: Anker Recalls 1.1 Million PowerCore 10000 Power Banks https://tidbits.com/2025/06/13/anker-recalls-1-1-million-powercore-10000-power-banks/ Watch Out for Malicious Unsubscribe Links https://lifehacker.com/tech/watch-out-for-malicious-unsubscribe-links Your Questions in the Meta AI App Might Be Posted Publicly https://lifehacker.com/tech/how-to-keep-your-meta-ai-questions-private Guests: Web Bixby has been in the insurance business for 40 years and has been an Apple user for longer than that.You can catch up with him on Facebook, Twitter, and LinkedIn. Brian Flanigan-Arthurs is an educator with a passion for providing results-driven, innovative learning strategies for all students, but particularly those who are at-risk. He is also a tech enthusiast who has a particular affinity for Apple since he first used the Apple IIGS as a student. You can contact Brian on twitter as @brian8944. He also recently opened a Mastodon account at @brian8944@mastodon.cloud. David Ginsburg is the host of the weekly podcast In Touch With iOS where he discusses all things iOS, iPhone, iPad, Apple TV, Apple Watch, and related technologies. He is an IT professional supporting Mac, iOS and Windows users. Visit his YouTube channel at https://youtube.com/daveg65 and find and follow him on Twitter @daveg65 and on Mastodon at @daveg65@mastodon.cloud. Dr. Marty Jencius has been an Associate Professor of Counseling at Kent State University since 2000. He has over 120 publications in books, chapters, journal articles, and others, along with 200 podcasts related to counseling, counselor education, and faculty life. His technology interest led him to develop the counseling profession ‘firsts,' including listservs, a web-based peer-reviewed journal, The Journal of Technology in Counseling, teaching and conferencing in virtual worlds as the founder of Counselor Education in Second Life, and podcast founder/producer of CounselorAudioSource.net and ThePodTalk.net. Currently, he produces a podcast about counseling and life questions, the Circular Firing Squad, and digital video interviews with legacies capturing the history of the counseling field. This is also co-host of The Vision ProFiles podcast. Generally, Marty is chasing the newest tech trends, which explains his interest in A.I. for teaching, research, and productivity. Marty is an active presenter and past president of the NorthEast Ohio Apple Corp (NEOAC). Jim Rea built his own computer from scratch in 1975, started programming in 1977, and has been an independent Mac developer continuously since 1984. He is the founder of ProVUE Development, and the author of Panorama X, ProVUE's ultra fast RAM based database software for the macOS platform. He's been a speaker at MacTech, MacWorld Expo and other industry conferences. Follow Jim at provue.com and via @provuejim@techhub.social on Mastodon. Support:      Become a MacVoices Patron on Patreon      http://patreon.com/macvoices      Enjoy this episode? Make a one-time donation with PayPal Connect:      Web:      http://macvoices.com      Twitter:      http://www.twitter.com/chuckjoiner      http://www.twitter.com/macvoices      Mastodon:      https://mastodon.cloud/@chuckjoiner      Facebook:      http://www.facebook.com/chuck.joiner      MacVoices Page on Facebook:      http://www.facebook.com/macvoices/      MacVoices Group on Facebook:      http://www.facebook.com/groups/macvoice      LinkedIn:      https://www.linkedin.com/in/chuckjoiner/      Instagram:      https://www.instagram.com/chuckjoiner/ Subscribe:      Audio in iTunes      Video in iTunes      Subscribe manually via iTunes or any podcatcher:      Audio: http://www.macvoices.com/rss/macvoicesrss      Video: http://www.macvoices.com/rss/macvoicesvideorss

Jim and Chris begin with three PSAs on Social Security experiences, then answer questions on fixed indexed annuities with market value adjustments, SPIA payout options for the Minimum Dignity Floor™, and the tax aggregation rule for MYGAs.(11:30) In this PSA Georgette clarifies that her husband, born February 1, received January benefits at full age 70, […] The post Social Security PSAs, FIAs, SPIAs, and MYGAs: Q&A #2525 appeared first on The Retirement and IRA Show.

Send us a textBack in the 1980s, everyone, and I mean everyone, was trying to spread one simple message: Drugs Are Bad! There were a ton of PSAs telling kids to leave narcotics alone. Celebrities said to stay clean, and networks invested in one off specials to keep kids from taking one toke over the line. Or any tokes for that matter.Here now is the nexus of these specials, a hybrid of PSAs, The Flintstone Kids, and a certain gloved singer who was high... on the charts at this time. Its The Flintstone Kids "Just Say No" special.Enjoy, and be sure to listen sober. Wink. Thanks for ‘tooning in.  Share With Us: SatMornPod@hotmail.comBluesky: @SatMornPodBe sure to find me and like-minded creators at TheRetroNetwork.comYouTube Us: tinyurl.com/yyhpwjeo (Don't waste your time)   Featured Music:“Nostalgic Happy Music” by AudioJungle - https://www.youtube.com/watch?v=QtxSUR6MQhw&t=2s “Happy Life” by Fredji - https://www.youtube.com/watch?v=KzQiRABVARk Various Music by Oneul - https://www.youtube.com/watch?v=by302C2YhxY “I Feel You” by Kevin MacLeod” - https://www.youtube.com/watch?v=Uw8E3jjbUCE “Nostalgic” by OrangeHead - https://www.youtube.com/watch?v=wExcRoNNzAc “Breakfast Club” by Vodovoz - https://www.youtube.com/watch?v=2Spi22l3m5I “Horizons” by Atch - https://www.youtube.com/watch?v=y-u53MADIag “80's Hijack” by Gee - https://www.youtube.com/watch?v=ndVqzJ9Lk6M&t=26s “Synthmania” by Vodovoz - https://www.youtube.com/watch?v=M6r20TKnA6M “United” by Vodovoz - https://www.youtube.com/watch?v=ArjGQFCcHxA “Cool Blue” by Vodovoz - https://www.youtube.com/watch?v=Lp5cxZWP-wc   #ABC #NBC #CBS #The80s #80s #cartoons #cartoon #animation #SaturdayMorning #1980 #1981 #1982 #1983 #1984 #1985 #1986 #1987 #1988 #1989 #Filmation #HannaBarbera #DePatieFreleng #RubySpears #Disney #Superheroes 

Today we have the June 16, 1945, edition of Alex Drier's Weekly News Analysis as it aired over NBC. We've followed that news report with a few short war PSAs, advertisements, and songs.Visit our website at BrickPickleMedia.com/podcasts. Subscribe to the ad-free version at https://podcasters.spotify.com/pod/show/worldwar2radio/subscribe.

CBS considers airing PSAs to settle Trump lawsuit, RFK Jr. offers to rescue bird flu-infected ostriches, HHS cuts Moderna's vaccine funding, and AI threatens half of all entry-level white-collar jobs. NewsTrump legal team, Paramount mull proposal for CBS to run PSAs for causes favored by prez to break quagmire over $20B lawsuit: sourcesBehind the Curtain: A white-collar bloodbathHHS cancels funding for Moderna to develop vaccines to combat bird fluRFK Jr offers to save Canadian ostriches with suspected bird flu and move them to US Follow @PodSaveThePeople on Instagram.

Carey is radicalized by Fire Island and drops multiple Dorinda references in this very special, very chintzy episode. His magical tale of going septic and wearing a stent and purse of antibiotics and subsequent digestive woe. Toenail removal and a discussion of disturbing doctors. A lengthy analysis of sunflowers. Conversely, shocking caller opinions on roses. Carey shares dog perfume tips. An exploration of flat Christina Aguilera karaoke. Many helpful PSAs.

A vintage videotape yields a bumper crop of L.A.based commercials, PSAs and promos that have Andrew and Vieves feeling nostalgic for the City of Angels. Plus, a Chicago Bulls great is either shilling for sandwiches or auditioning for the adult film industry. Jury's still out. Here are links to the ads we talked about on this week's show: Allstate: Mayhem Is The Voice Inside Your Head https://www.youtube.com/watch?v=fXPAy43My4w VCR Plus https://youtu.be/jc3fBQM111k Pepsi + Nintendo Commercial (ft. Bo Jackson) (1991) https://youtu.be/XtGpdzCRZ-M?si=6C7W63gWCSjXjzo3 Atari Lynx Holiday Pack Commercial (1991) https://youtu.be/CQ9ebE_4bcY?si=_stwHKqwsCPRd62z Lakers vs Celtics KCAL 9 Commercial (1991) https://www.youtube.com/watch?v=x6yaiMkQkYo KCAL 9 Raiders Promo (1991) https://youtu.be/vgqcU4hJZlc?si=yyvKFrORxvyPy9Op Injury Hotline Commercial: Job Stress & Harassment (1991) https://youtu.be/2MZ4Y0IaY6E Finders Car Insurance Commercial (1991) https://youtu.be/JP4UIalSz-c WeTip Drug and Crime PSA - KTTV 11 (1982ish) https://www.youtube.com/watch?v=Qmg00cHUMuc American Heart Association PSA ft. Earl Anthony (1982) https://www.youtube.com/watch?v=DSIap2ZuXAQ National Literacy Hotline PSA (1991) https://www.youtube.com/watch?v=LBHC30Xou28 Sierra Cars Commercial (1991) https://youtu.be/8nHvh0FvSks Five Dollar Clothing Store (1) https://youtu.be/PAV7M7tQ4QQ Five Dollar Clothing Store (2) https://youtu.be/pFiA3MV1ayw Maxwell House Commercial - Coffeehouse Coffee (1995) https://www.youtube.com/watch?v=pqdivYm7Sog Mr. Submarine (ft. Scottie Pippen) https://www.youtube.com/watch?v=40YkCQcMCpQ

Watching cartoons after school, they tried to help us, they tried to keep us on the straight and narrow ... but they made us laugh!

Matt is joined by Risinger Build Executive Project Manager Daniel Glauser to discuss pre-construction service agreements (PSAs), emphasizing the importance of getting paid for the extensive time and effort builders invest before actual construction begins. They explain how PSAs help weed out unserious clients, foster transparent collaboration with architects and homeowners, and ultimately ensure a smoother, more efficient building process. Matt and Daniel outline Risinger Build's current process, which includes an initial discovery phase, a high-level estimate based on preliminary plans, and a formal PSA requiring a $20,000 deposit billed against their time. This allows them to guide clients early on, avoid surprises, and align budget expectations. They encourage other builders—even those working on smaller projects—to adopt similar practices, advocating for industry-wide change through local builder networks. Both Builders encourage others to value their time and expertise and move away from outdated bidding practices that devalue the work they do. By doing so, builders can cultivate better client relationships, make more informed decisions, and improve outcomes for everyone involved in the building process.Thank you to episode sponsors Huber & Truss. Learn more at huberwood.com & trusspayments.com.Find Daniel on the Web:Website: https://risingerbuild.com/Instagram: @risingerbuild_atx & @glauserbuilding Save the Date for Build Show LIVE 2025 in Dallas, TX: October 16-18, 2025!Don't miss a single episode of Build Show content. Sign up for our newsletter.

Today on Normal World, Dave Landau, 1/4 Black Garrett, and Angela dig into the viral case of Shiloh Hendrix, a woman who called an autistic Black child the N-word—and somehow ended up a millionaire through GoFundMe. The crew breaks down how blatant racism is being rebranded as “free speech” and how both political extremes have replaced common sense with outrage. They reflect on Trayvon Martin, systemic injustice, and the emergence of a “woke right” that mirrors the same behavior it once ridiculed. From antisemitism to identity tribalism, they call out the absurdity of online purity tests and culture war grifting. Faith, race, government distrust, and the erosion of empathy all come into focus—before spiraling into hilarious chaos featuring weed PSAs, catnip trivia, food rankings, Mexican chefs, and a deep dive into the density of flight attendant BBLs. Learn more about your ad choices. Visit megaphone.fm/adchoices

Anna and Raven talk about things that you shouldn't ask friends! You'll never guess what they don't want to help a friend out with! There are a lot of viral heatless hairstyles to achieve effortless curls! Anna and Producer Julie put them to the test this week! Find out if they worked on Instagram @AnnaAndRaven Rules of the road! Anna and her family take a lot of road trips and shares the top things that are rules during the trip! Are you up to date on this week's biggest news story? Anna and Raven will get you caught up on the trending news stories including the Met Gala last night! Katie the Garden Lady shared a secret hack on how to make flowers grow! Raven tries the method to see if he can have a green thumb! If you like your marriage and don't want an argument, there is one thing you should avoid doing this summer! Anna and Raven talk about the renovations that almost destroyed their marriage! Happy Teacher Appreciation Day! Anna, Raven, Producer Julie, and Producer Justin share the teacher that had the biggest impact on them! Anna, Raven, Producer Julie, and Producer Justin share personal PSA's about what bothers them about cars! Blake and Jamie's 7-year-old son threatens to run away anytime his parents get upset with him. He packs a little bag and everything.  Jamie always folds and ungrounds him/unpunishes him.  She's worried about traffic, their local wooded area, strangers, etc.  Blake says they should just call his bluff and teach him a lesson...there are Ring cameras all over the neighborhood, he will be back in an hour anyway. Jamie and Mike have a chance to win $3000! All they have to do is answer more pop culture questions than Raven in Can't Beat Raven! 

This week, Wes, Matt, Jeff and Becca talk Star Wars Day, Devo, great PSAs, Danny Glover, traffic updates, bad public defecation, and debate the best brand of sink products or best brand of mayo. 

Dr. Rohan Garje shares the updated recommendations for the ASCO guideline on systemic therapy for patients with metastatic castration-resistant prostate cancer. He discusses the systemic therapy options for patients based on prior therapy received in the castration-sensitive and non-metastatic castration-resistant settings. He emphasizes personalizing treatment choices for each individual, considering patient-specific symptoms and signs, treatment-related toxicities, potential drug interactions, cost, and access. He also reviews recommendations on response assessment. The conversation wraps up with a discussion of potential future updates to this guideline, as the guideline transitions into a “living guideline” on mCRPC. Read the full guideline update, “Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update”. Transcript This guideline, clinical tools, and resources are available at www.asco.org/genitourinary-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology.      Brittany Harvey: Hello and welcome to the ASCO Guidelines Podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges and advances in oncology. You can find all the shows, including this one at asco.org/podcasts. My name is Brittany Harvey and today I'm interviewing Dr. Rohan Garje from Miami Cancer Institute Baptist Health South Florida, lead author on, “Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.” Thank you for being here today, Dr. Garje. Dr. Rohan Garje: Absolutely. Thank you so much for having me, Brittany. Brittany Harvey: And then before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines and ensuring that the ASCO Conflict of Interest Policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Garje, who has joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So then, to start on the content of this guideline, first, could you provide us an overview of the purpose of this guideline update? Dr. Rohan Garje: Sure. So ASCO has guidelines for prostate cancer and the specific guideline which we have updated for metastatic castrate-resistant prostate cancer was originally published in 2014. It's almost a decade. It's been a long time due for an update. Over the last decade, we have seen a lot of advances in the treatment of prostate cancer, specifically with regards to genomic testing, newer imaging modalities, and also the treatment landscape. Now we have newer options based on genomic targets such as PARP inhibitors, we have radiopharmaceuticals, a newer variant of chemotherapy, and also some specific indications for immunotherapy which were not addressed previously. Because all these advances have been new, it was really important for us to make an update. In 2022, we did make a rapid update with lutetium-177, but these additional changes which we have seen made it an appropriate time frame for us to proceed with a newer guideline. Brittany Harvey: Absolutely. It's great to hear about all these advances in the field to provide new options. So I'd like to next review the key recommendations from this guideline. So let's start with the overarching principles of practice that the panel outlined. What are these key principles? Dr. Rohan Garje: As a group, all the panel members came up with some ground rules: What are necessary for all our patients who are being treated for metastatic CRPC? First, the founding aspect was a definition for what is metastatic CRPC. So we defined metastatic CRPC as castrate level of testosterone with evidence of either new or progressive metastatic disease on radiological assessments or patients who have two consecutive rising PSAs in the setting of existing metastatic disease. We also emphasized on the need for germline and somatic testing for patients with metastatic prostate cancer at an earliest available opportunity because it is critical to select appropriate treatment and also right treatment for patients at the right time. And we actually have a concurrent guideline which addresses what genes to be tested and the timing. The other principles are patients should continue to receive androgen deprivation therapy or undergo surgical castration to maintain castrate level of testosterone. Now the key aspect with these guidelines is personalizing treatment choices. As you can see the evolution of treatment options for prostate cancer, the drugs that were initially developed and approved for prostate cancer were primarily in castrate-resistant settings, but now most of these drugs are being utilized in castrate-sensitive. So, when these patients develop castration resistance, the challenges are there are no appropriate particular drug-specific guidelines they meet. So, it's very important for the clinicians to be aware of what treatments have been received so far prior to castration resistance so that they can tailor the treatment to patient specific situations. In addition, prior to choosing a therapy, it is important for the physicians to consider patient specific symptoms or signs, treatment-related toxicities, potential drug interactions, cost, and also access to the drugs. There may be multiple treatment options available for the patients, but for a patient specific scenario, there may be a drug that may be more promising than the others. So, it is important to tailor the drug choices based on patients' unique circumstances. The panel also recommends to early integrate palliative and supportive care teams for symptom management and also discuss goals of care with the patient as each patient may have unique needs and it's important for physicians to address those concerns upfront in the care. The panel also suggests patients to receive RANK ligand inhibitors such as denosumab or bisphosphonates such as zoledronic acid to maintain the bone strength to prevent skeletal-related events. Finally, I would like to also emphasize this point about the lack of randomized clinical trial data for optimal sequencing of therapies for patients with metastatic CRPC. As I previously alluded, we have taken into account all ongoing clinical trials, prior published data, and came up with a format of preferred drugs based on prior treatments and, I think, by following these several clinical principles which I just mentioned, we can optimally choose and utilize best treatments for patients with metastatic CRPC. Brittany Harvey: Absolutely. These principles that you just outlined are important for optimal patient care, and then I want to touch on one of those things. You talked importantly about the treatments received so far. So in the next set of recommendations, the role of systemic therapy was stratified by the prior therapy received in the castration-sensitive and non-metastatic castration-resistant setting. So starting with what does the panel recommend for patients who are previously treated with androgen deprivation therapy alone in these previous settings and whose disease has now progressed to metastatic castration-resistant prostate cancer? Dr. Rohan Garje: There are multiple treatment options based on prior treatment received. So for patients who received only ADT for their castration-sensitive disease, the panel strongly urges to get HRR testing to check for homologous recombinant repair related changes, specifically for BRCA1 and BRCA2 mutations, because we have three studies which have really shown significant clinical benefit for patients who have BRCA1 and BRCA2 mutations with drugs such as the combination of talazoparib and enzalutamide or olaparib with abiraterone or niraparib with abiraterone. Unless we test for those mutations, we'll not be able to give these agents upfront for the patients. In the HRR testing, if patients have HRR alterations but they are in genes which are non-BRCA, the guideline panel recommends to utilize talazoparib and enzalutamide based combination therapies. Now, if they don't have HRR alterations then there are multiple treatment choices available. It could either include androgen receptor pathway inhibitors such as abiraterone with prednisone. We could also consider docetaxel chemotherapy. The alternate choices for androgen receptor pathways include enzalutamide or the newer agents such as apalutamide and docetaxel. So, as you can see there are multiple options available, but the panel definitely emphasizes to test for HRR testing because this gives patients access to more precision therapies at this point. There may be various scenarios where a unique drug may be available for a specific patient situation. For example, patients who have very limited disease burden and may have one or two metastatic lesions, after a multidisciplinary discussion, targeted local therapies such as radiation or potentially surgery could also be offered. In select patients who have very indolent disease where they are castrate-resistant based on slow rising PSA, low-volume disease or asymptomatic disease can consider sipuleucel-T. And in patients who have bone-only metastatic disease, we could also consider radium-223, which is primarily now utilized for patients who have symptomatic bone disease. Brittany Harvey: Great. I appreciate you reviewing all those options and talking about how important it is to tailor treatment to the individual patient. So then the next category of patients, what is recommended for those who have been previously treated with ADT and an androgen receptor pathway inhibitor and whose disease has now progressed to metastatic castration-resistant prostate cancer? Dr. Rohan Garje: So for patients who received ADT along with an androgen receptor pathway inhibitor, which we consider would be a most common cohort because most patients now in castration-sensitive setting are receiving androgen receptor pathway inhibitor. It was different in the past where five or six years back ADT alone was the most common treatment, but fortunately, with enough awareness and education, treatment choices have improved. Patients are now receiving ADT and ARPI as the most common choice of drug. Once again, at this point the panel emphasizes to consider HRR testing in there is enough data for us to suggest that patients who have alterations in the HRR pathway definitely will benefit with the PARP inhibitor. You know the multiple options, but specifically we speak about olaparib. And then if they are HRR-negative, we prefer patients receive agents such as docetaxel or if they are intolerant to docetaxel, consider cabazitaxel chemotherapy, options such as radium-223, and if they have a specific scenario such as MSI-high or mismatch repair deficiency, pembrolizumab could also be considered. The panel also discussed about the role of a second ARPI agent. For example, if patients progressed on one androgen receptor pathway inhibitor, the second androgen receptor pathway inhibitor may not be effective and the panel suggests to utilize alternate options before considering androgen receptor pathway inhibitor. There may be specific scenarios where a second ARPI may be meaningful, specifically, if alternate choices are not feasible for the concern of side effects or toxicities or lack of access, then a potential ARPI could be considered after progression on ARPI, but the panel definitely encourages to utilize alternate options first. Brittany Harvey: Great. Thank you for outlining those options as well for those patients. So then the next category, what is recommended for patients who have been previously treated with ADT and docetaxel? Dr. Rohan Garje: For patients who received ADT and docetaxel and were never treated with androgen receptor pathway inhibitors, the panel again emphasizes on HRR testing. If they have BRCA1 and 2 mutations, the combination therapies of talazoparib with enzalutamide, olaparib with abiraterone, or niraparib with abiraterone are all good choices. If they don't have BRCA mutations but they have other HRR mutations, the panel suggests to potentially utilize talazoparib with enzalutamide. And if they do not have any HRR alterations, the options could include androgen receptor pathway inhibitors such as abiraterone or enzalutamide. I want to emphasize that these are preferred options, but not the only options. As you can see, there are multiple options available for a particular clinical situation - so the ability of the physicians to access particular combinations, the familiarity of those drugs or the patient's unique situation where they have other medications which can potentially interact with a choice of agents. So I think based on access, based on cost and patients' concurrent illness with potential drug interactions can make one particular combination of therapy better over the other options. Brittany Harvey: Absolutely. That's key to keep in mind that access, contraindications, and cost all play a role here. So then the next set of recommendations. What are the key recommendations for patients who have previously been treated with ADT, an androgen receptor pathway inhibitor, and docetaxel who now have mCRPC? Dr. Rohan Garje: Yes. In this group, the options remain, again, broad. We utilize PSMA imaging here specifically and if they are positive on PSMA imaging, lutetium-177 is a good option. If they do not have PSMA-positive disease on PSMA imaging but if they have HRR alterations, olaparib could be utilized. And if they are negative on PSA imaging, they don't have HRR alterations, then alternate options could include cabazitaxel, radium-223. And if they have MSI-high or deficiency in mismatch repair, pembrolizumab could be utilized in this setting. Brittany Harvey: Thank you for outlining those options as well. So then next the panel addressed treatment options for de novo or treatment emergent small cell neuroendocrine carcinoma of the prostate. What are those key recommendations? Dr. Rohan Garje: Yes. This is a very high unmet need group because there are limited clinical trials, especially prospective clinical trials addressing treatment options for this group. Most of our current guidelines are always an extrapolation from lung small cell cancer based guidelines, but the panel recommends to utilize cisplatin or carboplatin along with etoposide as a preferred choice for this group. Also, an alternate option of carboplatin along with cabazitaxel could be considered for this cohort. The panel also encourages participation in clinical trials. There are numerous trials ongoing now in smaller phase studies and I think it's important for patients to consider these trials as well, because this will give them access to newer agents with potential biological targets. In addition to these agents in specific scenarios or potentially case by case basis, because we don't have prospective data, so we have made it as a select case by case basis to consider adding immunotherapy along with platinum-based chemotherapy followed by maintenance immunotherapy, which is currently a standard of care in small cell lung cancer. But the data is so limited in prostate cancer, so the panel suggested that it has to be a case by case basis only. The alternate options also include lurbinectedin, topotecan, tarlatamab upon progression on platinum-based chemotherapy. Brittany Harvey: Yes. It's important to have these recommendations in these unique situations where there is really a lack of data. So then the final set of recommendations I'd like to cover, what does the panel recommend for how clinicians should assess for response while patients are on systemic therapy and what scans are recommended for this response assessment? Dr. Rohan Garje: Yes. Again, this is another strong emphasis of the panel for global assessment of the patients. Traditionally, patients and physicians per se are heavily reliant on PSA as an accurate marker for response. This is in fact true in earlier phases of prostate cancer either in castrate-sensitive setting or localized prostate cancer setting. But as patients evolve into castrate-resistant, we don't want to heavily rely on PSA alone as a marker of response. The panel suggests to incorporate clinical response, radiological response, and also include PSA as a component, but not just rely primarily on PSA. So the panel also suggests that patients should get a bone scan and a CT scan every three to six months while on treatment to assess for appropriate response or for progression. And now one key important aspect, we are all aware about the evolving role of PSMA-based imaging with several of these new agents that are currently available. We do acknowledge these scans definitely have an important role in the care for patients with metastatic prostate cancer. Currently, the utility is primarily to select patients for lutetium-based therapy and also in situations where the traditional scans such as technitium 99 bone scan or CT scan are equivocal, then a PSMA-based imaging can be helpful. Now we are also aware that there are newer studies coming up, prospective data coming up for the role of PSMA-based imaging for response assessment. We are hoping to update the guidelines if we get access to newer data, but currently we have not recommended the utility of PSMA-based imaging for response assessments. Brittany Harvey: Understood. And I appreciate you describing where there is data here and where there's a lack of data to currently recommend. And we'll look forward to future updates of this guideline. Coming back to – at the start you mentioned how much has changed since the last guideline update. So Dr. Garje, in your view, what is the importance of this update and how will it impact both clinicians and patients with metastatic castration-resistant prostate cancer? Dr. Rohan Garje: The updated guidelines are designed to have a significant impact on clinical practice and also patient outcomes by providing clinicians with a comprehensive evidence-based framework for managing patients with metastatic CRPC. And also, by using these guidelines can make informed decisions, can select therapies tailored to patients' unique genomic status, clinical situation, where they are in the course of the cancer based on what they received previously. Also utilizing these guidelines, we can potentially improve patient outcomes, improve survival, and importantly have efficient use of healthcare resources. Brittany Harvey: Absolutely. We're always looking for ways to improve patient outcomes and survival. I want to wrap us up by talking a little bit about the outstanding questions in this field. So earlier you had mentioned about prospective data to come about PSMA PET scans, but what other outstanding questions are there for patients with metastatic castration-resistant prostate cancer? And what evidence is the panel looking forward to for future updates? Dr. Rohan Garje: We do have now rapidly evolving data specifically about the utility of the radiopharmaceutical lutetium-177 prior to chemotherapy. We are hoping that with newer data we can make some changes to the guideline based on that. We are also looking at newer drugs that are coming up in the pipeline, for example, androgen receptor degraders. We are looking at data that might potentially help based on bispecific T-cell engagers and newer radiopharmaceuticals. So I think in the next few years, we will definitely update all the guidelines again. But this time we are trying to do it more proactively. We are following a newer model. We are calling it as ‘living guidelines' where we are actually utilizing week by week updates where we look at the literature and see if there is any potential practice impacting change or publication that comes up. And we are trying to incorporate those changes as soon as they are available. That way patients and practicing physicians can get the latest information available through the guidelines as well. Brittany Harvey: That's great to hear. Yes, we'll await this data that you mentioned to continuously update this guideline and continue to improve patient outcomes for the future. So Dr. Garje, I want to thank you so much for your time to update this guideline. It was certainly a large amount of recommendations, and thank you for your time today, too. Dr. Rohan Garje: Thank you so much for having me here. And it's always nice talking to you. Brittany Harvey: And finally, thank you to our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline, go to www.asco.org/genitourinary-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app, which is available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

There have been so many times that I've made a mental note that I need to include more photojournalism on the show, only to have a mental dog eat my homework. Finally, today, I am checking that off the list. Still, if I'm being honest, it wasn't my mental note that made this show happen. It was a series of events that include an email, a referral, and a conference. It ends out that today's guest had reached out to me directly back in August of last year. His email started with "Hey Steve. I have been a loyal listener to your podcast for years. It's been my favorite photo-related podcast by far. I'd love to be featured on your show.", but unfortunately at the time I wasn't in need of any guests - I try not to book too far out these days. Still, I checked out his work and figured someday I needed to follow up. Then, a few months ago, my buddy Kersten Luts, of the Camera Shake Podcast, mentioned a guest that he'd had on his show, and suggested I should get him on my show. When he mentioned the name, Kevin Painchaud, I had the feeling I had heard of him. Still, I was a bit busy at that point, so I didn't really pursue it. Which brings us to the conference part of the story... In February I want to Imaging USA in Texas, mainly to see some friends, like Larry and the gang from Platypod, and Kersten, who was traveling in from London. While there I met Kevin, and that meeting finally got this show off the ground. Kevin is a photojournalist for Lookout Santa Cruz, or more to the point he's THE photojournalist for the all digital daily news organization. His road to, and through, photojournalism is an interesting one. He fell in love with photography in High School, but then, just shy of his 16th birthday, he was a passenger in a car that hit a tree and rolled down a hill. Kevin ended up badly injured, and in a coma for four days. He woke up on his 16th birthday with a new found gratitude to be alive, and an appreciation for people and their stories. Fast forward to 2023, when Santa Cruz County was battered by relentless atmospheric rivers, and destruction as a result, and Lookout Santa Cruz's newsroom of 10 people was tasked with documenting the devastation and providing critical updates. A year later, that hard work would pay off. The Managing editor, Tamsin McMahon, had spent weeks secretly compiling all the articles, photos, and videos, to create a beautiful timeline of their coverage. Why? She was entering the coverage for a chance at the Pulitzer Prize. That had to be one hell of a Zoom meeting when she told the staff, that had no clue she'd done this, that they had won. Now, with 25 years of experience, Kevin has shot for numerous magazines and newspapers, and his work has been featured on prominent news outlets including ABC News, CBS, The Washington Post, NPR, CNN, and MSNBC. His videos were also featured on ABC's World News Tonight. Kevin has produced several feature films, directed TV show pilots, and even earned an Emmy nomination for his music-focused TV show, Muzic on the Edge. One of Kevin's projects that really intrigues me is that he directed PSAs for Aerosmith. Join Pulitzer Prize-winning photojournalist Kevin Painchaud and me as we discuss his road to photojournalism, and as we dissect his award winning image of the CZU Lightning Complex Fire, on this Behind the Shot. Connect with Kevin Portfolio: kevinpainchaud.com Instagram: @painchaudkevin Kevin's Photographer Picks Shumel Thaler: shmuelthaler.com | @shmuelthaler Patrick Tehan: tehanphotography.com | @tehanpatrick John Hefti: johnhefti.com | @johnp.hefti Kevin's Other Work

This week, we look at public service announcements. PSAs have to compete with - not just other PSAs - but with all other commercials out there. And do it with an iota of the budget. It requires exceptional creativity. We'll talk about how Elvis got teens to get a polio vaccine, and a drinking & driving commercial recorded by drunk actors. --------Looking for where to find a discount on the Saily data plan?Get an exclusive 15% discount on Saily data plans! Use code TERRY at checkout. Download Saily app or go tohttps://saily.com/terry" Hosted on Acast. See acast.com/privacy for more information.

It is a rare occasion when the Screen Addicts review an individual film, but we had to go back into the vast, vampiric world created by director Ryan Coogler and review the latest theatrical hit from Warner Bros.   We also have a few PSAs about the annoyance that is a "Movie Talker." Send us a textSupport the showIf you are feeling anxious, depressed or angry and need someone to talk to, visit Better Help to speak to a licensed professional. Use the promo code: screenaddicts and receive 10% off your first month. Just follow this link: https://tr.ee/kWT1K0AfHj Visit our Linktree for show info and our Merch Store: https://linktr.ee/screenaddictspodcastSubmit any thoughts or questions to: screenaddictpodcast@gmail.com

We're baaaaaack (again)! After taking a 3 year long break, we're ready to start telling you stories!   We start off with some updates on our personal paranormal experiences. Sage then tells us the story of the Dodleston messages, as detailed in The Vertical Plane by Ken Webster. This one has everything - ghosts, time travel, haunted technology, creepy poetry, and more! A LOT happens in this story, so much that we'll have a Part Two coming soon.   Sam ends the show by sharing with us their recent experiences in Florida. We talk about what it is like to buy legal cannabis there, which leads to some unsolicited PSAs about legalization and drug use.   Thank you for listening! Have a safe 4/20 and stay hydrated!

The tariffs on China are now effectively 145% and penalties tied to Venezuelan oil could raise that to 170%. Trump's tariff policies are nearing the triple digits, so the level of uncertainty filling every board room is chilling.Join the Patreon here: https://www.patreon.com/PeterZeihanFull Newsletter: https://mailchi.mp/zeihan/of-tariffs-manufacturing-and-psas

We're diving into the New Teen Titans anti-drug PSAs from the height of Nancy Reagan's "Just Say No" crusade. These comics are just like the campaign: well-meaning, wildly over-the-top, and completely out of touch with the actual issue.   ----more---- For the transcript of this episode, head over to https://www.tencenttakes.com/transcripts.   Email: tencenttakes@gmail.com Instagram: @Tencenttakes Facebook: /Tencenttakes Mastodon: retro.pizza/@tencenttakes Our banner art is original work by Sarah Frank  (https://www.lookmomdraws.com/)

Hi Beloved. (a brief personal memo before I wrap you in love with this audio and dialoged journey. The only thing I know….is being a (mystic) lone wolf. Drumming to my own beat, in constant conversation with God and my angels. I think it's normal - but other's likely don't relate. But maybe you do? Feeling rich, even when you walk alone? Now this doesn't say I dont experience lonley-ness. You bet I f*****g do….BUT, staying in that frame is the energy of a victim. It leads me to asking - what is the deeper need, Kass? Anywhoo….I've created a life I love and a career that lights up my soul by being in deep intimate conversation with clients every day. If I'm not with clients, I'm writing to my clients as I channel God and life giving energy that is expressed through articles, art and creating new services - at the speed of light. Yet, I walk alone. No kids. No husband. Short of shaving my head - this is what society looks at and says “ what's wrong with her? She's a work aholic, etc.” But really? Even though I wanted a family, my soul's contract is clear. I am a women, that walks alone. NOW, step into this framing and see what hits your heart on your own journey. It's beyond profound and will change your relationship to SELF TRUST and EMPOWERMENT - no longer giving consent to society and personal toxic projections. I LOVE YOU. I walk with you. xo KassandraTAP INTO THE DIALOGUE

Ashe in America and Abbey Blue Eyes are joined by Maxanon and Christy Lupo for an epic episode covering everything from constitutional chaos to cryptid conspiracies. The crew kicks things off with a lively discussion on the Supreme Court's latest Voting Rights Act cases, then dives deep into Sasquatch sightings, DNA mysteries, and government coverups (complete with audio evidence and plush props). Things get spicy with a breakdown of cannabis propaganda through the ages, featuring wild anti-weed PSAs, pharmaceutical manipulation, and the history of hemp suppression. Sprinkle in some hilarious White Castle memories, a crash course on nutritional deficiencies, and a nod to the Nephilim, and you've got a full-spectrum truth bomb served up sandwich-style.  

This week's CodeCast summarizes the recent ICD-10-CM documentation guidelines instructions on sepsis, obesity, and COVID-19 reporting. Terry also provides more guidance on E/M risk in prescription drug management and caution with PSAs in patient documentation. Subscribe and Listen You can subscribe to our podcasts via: Apple Podcasts – https://podcasts.apple.com/us/podcast/codecast-medical-billing-coding-insights/id1305926627 Spotify – https://open.spotify.com/show/1lA69Q7EnjSMuVr3sXVWlX TuneIn – https://tunein.com/radio/CodeCast–Medical-Billing-p1056702/ YouTube […] The post ICD-10-CM April 1st Updates appeared first on Terry Fletcher Consulting, Inc..

8am- DIY PSAs, Band on Your Shirt and MORE full 1625 Mon, 10 Mar 2025 16:30:44 +0000 trTm83nkABiNjcRe8XNxTfVwcGCfYIM4 society & culture Klein/Ally Show: The Podcast society & culture 8am- DIY PSAs, Band on Your Shirt and MORE Klein.Ally.Show on KROQ is more than just a "dynamic, irreverent morning radio show that mixes humor, pop culture, and unpredictable conversation with a heavy dose of realness." (but thanks for that quote anyway). Hosted by Klein, Ally, and a cast of weirdos (both on the team and from their audience), the show is known for its raw, offbeat style, offering a mix of sarcastic banter, candid interviews, and an unfiltered take on everything from culture to the chaos of everyday life. With a loyal, engaged fanbase and an addiction for pushing boundaries, the show delivers the perfect blend of humor and insight, all while keeping things fun, fresh, and sometimes a little bit illegal. 2024 © 2021 Audacy, Inc. Society & Culture False https://player.amperwavepodcasting.com?feed-link=h

Seth and Sean dive into some breaking news that the Texans have agreed to a 1-year deal with DT Sheldon Rankins and have some disclaimers for those players hoping to come to the Texans.

Usually, city government social media pages aren't funny. But the City of Boise's social media team has cracked the internet code, turning PSAs about scooters, composting, and sewer-clogging “fatbergs” into viral gold. Host Lindsay Van Allen is talking with Elizabeth Kidd and Taylor Nash — two of the masterminds behind the city's Instagram and TikTok accounts. We're finding out about how they use humor to make local government fun and informative. Want some more Boise news? Head over to our Hey Boise newsletter where you'll get a cheatsheet to the city every weekday morning. Learn more about the sponsor of this March 4th episode: Treefort Music Fest Interested in advertising with City Cast Boise? Find more info HERE. Reach us at boise@citycast.fm. Learn more about your ad choices. Visit megaphone.fm/adchoices

CLIP- DIY PSAs full 305 Wed, 19 Feb 2025 16:59:22 +0000 mekVVgSiGul2ICdBUlaqjpt58mBhdqFy society & culture Klein/Ally Show: The Podcast society & culture CLIP- DIY PSAs Klein.Ally.Show on KROQ is more than just a "dynamic, irreverent morning radio show that mixes humor, pop culture, and unpredictable conversation with a heavy dose of realness." (but thanks for that quote anyway). Hosted by Klein, Ally, and a cast of weirdos (both on the team and from their audience), the show is known for its raw, offbeat style, offering a mix of sarcastic banter, candid interviews, and an unfiltered take on everything from culture to the chaos of everyday life. With a loyal, engaged fanbase and an addiction for pushing boundaries, the show delivers the perfect blend of humor and insight, all while keeping things fun, fresh, and sometimes a little bit illegal. 2024 © 2021 Audacy, Inc. Society & Culture False https://player.amperwavepodcasting.com?feed-link=https%3A%2F%2Frss.amperwave.n

One of the most amazing things about fly fishing is that the vast majority of our gear works great 100% of the time without paying any attention to it. One of the most frustrating things about fly fishing is when your gear suffers a catastrophic failure while you're on the water. I'm not saying that routine maintenance will avert all disaster. But it doesn't increase the odds; it certainly diminishes them. Today I walk through the relatively simple process than anyone with a tiny amount of mechanical know-how can follow to keep their reel running smoothly and ready for the upcoming season. I also offer up some of my routine fly line PSAs while I'm at it. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week we share the 2 most important PSAs you will ever need to know! Plus we chat about: circumcision, doctor's asking important questions, a trip down memory lane, a trick to warm up your hands, and more… It's all covered on this week's Nobody's Listening Right? Podcast. ▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬ Support NLR by supporting our amazing sponsors: Go to Zocdoc.com/NLR and download the Zocdoc app to sign-up for FREE and book a top-rated doctor. ▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬ Support the show! https://patreon.com/nobodyslisteningright Instagram: https://www.instagram.com/nobodyslisteningright TikTok: https://www.tiktok.com/@nobodyslisteningright Podcast: https://linktr.ee/nobodyslisteningright Website + Merch: https://www.nobodyslisteningright.com Shop with us: https://www.amazon.com/shop/nobodyslisteningright ▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬ Chapters 00:00 Intro 00:25 Lymphatic Face Massage 02:20 Why is it so hard to form new habits 08:37 Chlamydia Woes 27:30 Circumcision 32:01 A Trip Down Memory Lane 48:35 Warm Hands Trick Learn more about your ad choices. Visit megaphone.fm/adchoices

Friend, this topic is SO important I'm putting it back in front of you again. Here's the deal: Even people in strong, satisfying relationships can develop feelings of attraction for another person. It's part of the human experience. These feelings can be transient and meaningless... OR they could destroy your life, if you follow them.  Are crushes innocent, or on-ramps to an affair? Can you be "friends" with someone you have a crush on, without risking your relationship? What should you do when you're married, but have a crush on someone else? Oh, the questions! It happens: people in happy, healthy, committed relationships can still develop crushes on others. However, smart, self-aware people in committed relationships that they care about need to handle these maturely and with wisdom. That's what you'll learn how to do on today's show. We'll discuss:  The mechanics of a crush; how and why crushes develop The difference between a crush and a platonic friendship Why happy, committed married people can have crushes on others How crushes can turn into something more serious How to use self awareness, integrity, and honesty to protect your marriage How to use your crush experience in order to add energy and intimacy into your relationship Warning signs that your crush is developing into something else Why extramarital affairs are always a bad idea, and rarely end well How to stop having a crush on someone else How to avoid embarrassment and professional ruin if you have a crush on a coworker How to protect your relationship and stay true to your values even when you're having feelings for another. All this and more on today's episode of the Love, Happiness and Success Podcast. xoxo, Dr. Lisa Marie Bobby GrowingSelf.com Ps: As we discussed in this episode, part of your action plan needs to be leaning towards your partner in an authentic and emotionally intimate way, and that calls for excellent communication skills. To support you in this, please help yourself to my free two part communication skills training, "Communication That Connects." I made this for you!  ... LMB

Ben Lindbergh and Meg Rowley banter about a Tigers tweet about future first-pitch timing and other non-topical PSAs, provide a Secret Santa sign-up reminder, consider baseball authority figures who answer fan mail, discuss the impact that the changing economic landscape of college sports could have on MLB drafting and development, react to Danny Jansen's deal […]